TUMORAL DISEAS TREATED AT CNAO

icona cordomi3

icona tronco encefalico

 
 

icona sarcomi tessuti molli

 
 

icona sarcomi ossei2

icona meningiomi sito

 
icona orbitari sito

icona tumori acc

ADENOID CYSTIC CARCINOMA OF SALIVARY GLANDS

icona pediatrici

PEDIATRIC SOLID TUMORS

icona sindromi genetiche

TUMORS IN PATIENTS AFFECTED BY GENETIC SYNDROMES

icona recidive

RETREATMENT OF ALREADY RADIO TREATED AREAS
OTHER DISEAS OBJECT OF CLINICAL TRIAL

icona tumori pancreas

(Pre-op treatment/locally advanced inoperable tumors treatment)

icona prostata

 

icona tumore retto

incona seni paranasali

 
 

icona tumori cerebrali

 
 
 
The factors that condition the choice of a treatment with hadrontherapy are related mainly to the type of cancer and its natural history, i.e. its evolutionary behavior from the moment it occurs.
  • The histotype or the histology of the tumor (the type of healthy cell from which a tumor originates) is one of the most important factors that determines the decision for treatment with hadrons. There are certain types of cancers which have a particular capacity for rapid growth and microscopic spread to other organs which may not be visible in normal diagnostic tests. These types of tumors do not benefit from local treatments such as hadrontherapy, but need a systemic or pharmacological treatment that prevents the cancer’s spread.
  • Metastasis or the spread of the disease to other organs or tissues is often a criterion used to reject treatment with hadrons. When the disease has affected other organs far from its origin, it means that cancer cells have spread through the blood and/or lymphatic system. In these cases, local treatments such as radiotherapy or surgery must be substituted with systemic treatments that act in a widespread, i.e. diffuse, way.
  • Radiosensitive tumors. Tumors that require low doses of radiation to avoid their recurrence and to be “cured” do not need the relatively sophisticated treatment represented by hadrontherapy. In such cases X-ray radiation therapy has proven itself to be both effective and sufficient.
 
titolo visite guidate eng
 
The National Centre for Oncological Hadrontherapy organizes guided tours for students from high schools, universities, research institutes and scientific organizations. Among CNAO missions, besides patients' cure, there is also education to research and innovation, as an effective tool to raise young persons' interest in their future professions.
 
simbolo GUIDED TOURS
 
 
 
 
 
 

 

Latest News

April 01, 2019

Bando di concorso per tesi di laurea in radioterapia o radiodiagnostica per immagini.

Siamo lieti di comunicare il nominativo della vincitrice del bando di concorso: Dott.ssa Clara Gaetani per la tesi di laurea "Ruolo della risonanza magnetica multiparametrica nel predire il grading dei meningiomi" - UNIVERSITÀ DEGLI STUDI DI PAVIA - FACOLTÀ…
titolo lavora con noi eng

To apply at CNAO Foundation, always interested in evaluating professionals who are highly qualified, send your resume to the e-mail: cv@cnao.it

 
simbolo WORK WITH US
titolo 3 questions to

Monthly section to our experts  simbolo

3 punti di domanda

Iscriviti alla Newsletter

Iscriviti per rimanere sempre aggiornato sulle attività della Fondazione CNAO.

 

simbolo medico

Sei un medico? Clicca qui per iscriverti alla newsletter a te dedicata.

  • 3.png0.png9.png0.png0.png4.png1.png
  • Web Traffic:
  • Today 894
  • |
  • Yesterday 2331
  • |
  • This week 894
  • |
  • Total 3090041
Iscriviti alla nostra Newsletter
Iscriviti per rimanere sempre aggiornato sulle attività della Fondazione CNAO.

 

simbolo medico

Sei un medico? Clicca qui per iscriverti alla newsletter a te dedicata.